Risk Factors for Severe Hemorrhagic Transformation in Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator

Larrue, Vincent; von Kummer, Rüdiger; Müller, Achim; Bluhmki, Erich

doi:10.1161/01.str.32.2.438

Public

Risk Factors for Severe Hemorrhagic Transformation in Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator

Published in Stroke • Feb 1, 2001

Authors:

Vincent Larrue

Rüdiger von Kummer

Achim Müller

Abstract

BACKGROUND AND PURPOSE: Intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) improves the outcome for ischemic stroke patients who can be treated within 3 hours of symptom onset. The efficacy of thrombolysis has been demonstrated despite an increased risk of severe hemorrhag...

Subject

Medicine

Thrombolysis

Intracerebral hemorrhage

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!